Enal Razvi,
Managing Director,
Select Biosciences Inc

Enal Razvi, PhD is biotechnology analyst and Managing Director US at Select Biosciences. In this capacity he continuously tracks a number of fields in the scope of his industry coverage, authors market analysis reports in these areas, and works with companies worldwide in the areas of technology analysis, market research, strategy development, and operational roles. Dr. Razvi holds a doctoral degree in the biomedical sciences and was post-doctoral fellow under Ralph Steinman [Nobel Laureate in 2011] at The Rockefeller University, New York. For the last decade, Dr. Razvi has been focused on tracking the life sciences fields and has worked with numerous companies around the world.

Dr. Razvi can be reached at: enal@selectbio.us

The Worldwide Market for MicroRNA and Epigenetics: Research, Diagnostics, and Therapeutics

Select Biosciences industry tracking of the microRNA and Epigenetic fields has focused on qualitative and quantitative market trends based on primary market analyses. We have also conducted extensive analysis of all the publications in these fields which allow us to track the evolution of research trends in this interrelated spaces. These market analyses have been recently published in the Select Biosciences MicroRNAs and Epigenetics 2012 Market Reports, and in this presentation I will present a snapshot of the research trends in microRNAs and Epigenetics and frame them into their potential utility as biomarker classes for the future.